Department of Coloproctology, James Cook University Hospital, Marton Road, Middlesbrough, TS4 3BW, UK.
Int J Colorectal Dis. 2012 Mar;27(3):309-17. doi: 10.1007/s00384-011-1340-3. Epub 2011 Nov 9.
Although the regional lymph node status is essential for staging of colorectal cancer, the importance of the total number of collected nodes remains controversial. Our aim was to examine the impact of the metastatic lymph node ratio (LNR) on the survival of patients with Dukes C colorectal cancer.
All patients with Dukes C histology were selected from a prospectively collected database of all colorectal cancers resected between 1997 and 2007 at our institution. Demographic, histopathological and adjuvant treatment data were collected. The total number of positive lymph nodes was divided by the total number of lymph nodes examined to calculate the LNR. Patients were categorised into LNR groups 1 to 5 according to cut-off points: ≤0.1, 0.21, 0.36, 0.6 and ≥0.61. Survival from the date of operation was calculated using Kaplan-Meier estimates. Multivariate analysis was performed to identify those factors influencing survival.
Of 1,098 patients who underwent colorectal cancer resections, 41% were staged as Dukes C. Sixty-four percent of patients received chemotherapy. The median number of lymph nodes harvested and positive for tumour were 11 (range 1-52) and 4 (range 1-28), respectively. In patients who received chemotherapy, 5-year survival was 69.3% for LNR 1 and 23.6% for LNR 5. When no chemotherapy was given, the 5-year survival was 43.1% for LNR 1 and 8.7% for LNR 5.
Current evaluation of positive lymph nodes may not accurately stage Dukes C colorectal cancer. The assessment of the LNR is a useful prognostic method in this heterogenous group of patients.
虽然区域淋巴结状态对结直肠癌分期至关重要,但收集的淋巴结总数的重要性仍存在争议。我们的目的是研究转移性淋巴结比率(LNR)对 Dukes C 结直肠癌患者生存的影响。
从我们机构在 1997 年至 2007 年期间对所有结直肠癌患者进行的前瞻性收集数据库中选择所有 Dukes C 组织学的患者。收集了人口统计学、组织病理学和辅助治疗数据。将阳性淋巴结总数除以检查的淋巴结总数,以计算 LNR。根据截止点将患者分为 LNR 1 至 5 组:≤0.1、0.21、0.36、0.6 和≥0.61。从手术日期开始计算生存。采用 Kaplan-Meier 估计进行多变量分析,以确定影响生存的因素。
在接受结直肠癌切除术的 1098 名患者中,41%的患者分期为 Dukes C。64%的患者接受了化疗。中位数采集的淋巴结数量和肿瘤阳性数量分别为 11(范围 1-52)和 4(范围 1-28)。在接受化疗的患者中,LNR 1 的 5 年生存率为 69.3%,LNR 5 的 5 年生存率为 23.6%。如果没有给予化疗,LNR 1 的 5 年生存率为 43.1%,LNR 5 的 5 年生存率为 8.7%。
目前对阳性淋巴结的评估可能无法准确分期 Dukes C 结直肠癌。LNR 的评估是该异质患者群体中一种有用的预后方法。